Aprecia, CMIC to bring 3DP pharmaceutical products to Japan

Privately held Aprecia Pharmaceuticals, LLC (Aprecia) and CMIC CMO Co., LTD (CMIC CMO) have announced that both com...

March 15, 2019 | Friday | News
Fujifilm to acquire Biogen in a $890 M deal

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufactur...

March 13, 2019 | Wednesday | News
FDA accepts NDA for Lemborexant to treat Insomnia

Eisai Co., Ltd. and Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Pu...

March 12, 2019 | Tuesday | News
Oncoceutics licenses rights for its anti-cancer compound to Ohara

US based Oncoceutics, Inc. has announced the outlicense of the rights to the company’s lead compound, ONC201, for ...

March 12, 2019 | Tuesday | News
In a first ever head-to-head biologic clinical study in Ulcerative Colitis Takeda's Entyvio demonstrates superior results compared to Humira

Takeda Pharmaceutical Company Limited has announced results from the Phase 3b head-to-head VARSITY study which demonstra...

March 11, 2019 | Monday | News
Akili, Shionogi to develop digital therapeutics in key Asian markets

Akili Interactive, digital medicine company creating prescription treatments for people living with cognitive dysfunctio...

March 11, 2019 | Monday | News
Santen to raise disease awareness during World Glaucoma Week

Santen Pharmaceutical Co., Ltd. (Santen) announced on March 8 that as part of its initiatives to increase publ...

March 8, 2019 | Friday | News
Eisai submits marketing authorization application for Insomnia drug

Eisai Co., Ltd. has announced that a marketing authorization application has been submitted in Japan for lemborexant, an...

March 7, 2019 | Thursday | News
Study: Inflammation in the brain enhances the side-effects of hypnotic medication

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show h...

March 6, 2019 | Wednesday | News
Scientists develop stem cell-derived kidney tubules in microfluidic chips

Scientists from the Hubrecht Institute, the University of Utrecht, and MIMETAS have successfully grown kidney tubules de...

March 6, 2019 | Wednesday | News
Avita Medical to commercialize wounds treatment device in Japan

Australia based AVITA Medical, regenerative medicine company, announced that it has collaborated with COSMOTEC, an M3 Gr...

March 7, 2019 | Thursday | News
Novo Nordisk, Health2Sync collaborate for digital diabetes management

Health2Sync and Novo Nordisk Pharma Ltd. are partnering in Japan to support digital diabetes management and fa...

March 5, 2019 | Tuesday | News
Sagent Pharma acquires Raleigh manufacturing site

Nichi-Iko Pharmaceutical and Sagent Pharmaceuticals, a Nichi-Iko Group Company, a leader of specialty pharmaceutical pro...

March 5, 2019 | Tuesday | News
AGC completes acquisition of Malgrat Pharma Chemicals

Tokyo based AGC Inc. has announced on March 4 the completion of its acquisition of Spain's synthetic...

March 4, 2019 | Monday | News
Thermo Fisher’s oncomine test receives expanded approval

Thermo Fisher Scientific recently announced that the Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory a...

March 1, 2019 | Friday | News
CAC and rfxcel announce partnership for Pharmaceutical Traceability

CAC Corporation has signed a partnership agreement with rfxcel Corporation in the pharmaceutical traceability field...

February 28, 2019 | Thursday | News
Eisai receives approval for an additional indication of HUMIRA

AbbVie and Eisai have announced that they have received approval for an additional indication of HUMIRA®, a fully hu...

February 25, 2019 | Monday | News
Japan second fastest pharma growth in 2019- CPhI Report

The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of ...

February 21, 2019 | Thursday | News